Is this year’s COVID booster a good match for new variants?
Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...
How Bad Is This News for Novavax?
How bad is this news for Novavax? Let's find out. Image source: Getty Images.
STAT2d
More evidence on GLP-1s and opioid addiction
In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...
Benzinga (Video) on MSN2d
Novavax Shares Plummet 20% Following FDA Hold on Covid-Flu Vaccine Application
Novavax announced Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on its application for a ...
Becker's Hospital Review3d
Combination flu-COVID drug study paused after 'serious adverse event'
The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...
Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.
Novavax’s stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...